Halozyme Therapeutics, Inc. (HALO)
73.12
+1.92
(+2.69%)
USD |
NASDAQ |
Jan 06, 16:00
73.57
+0.46
(+0.62%)
After-Hours: 20:00
Halozyme Therapeutics Price: 73.12 for Jan. 6, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Johnson & Johnson | 204.76 |
| Merck & Co., Inc. | 108.88 |
| AIM ImmunoTech, Inc. | 1.28 |
| Protalix Biotherapeutics, Inc. | 1.765 |
| Armata Pharmaceuticals, Inc. | 5.98 |
Price Related Metrics
| PE Ratio | 15.37 |
| PS Ratio | 7.385 |
| PEG Ratio | 0.2676 |
| Price to Book Value | 17.06 |
| Price to Free Cash Flow | 15.24 |
| Earnings Yield | 6.51% |
| Market Cap | 8.598B |
| PEGY Ratio | 0.2676 |
| Operating PE Ratio | 12.45 |
| Normalized PE Ratio | 15.37 |